日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis

Nivolumab 治疗人乳头瘤病毒相关青少年复发性呼吸道乳头状瘤的临床活性

Ben C Creelan, M Usman Ahmad, Frank J Kaszuba, Farah K Khalil, Allison W Welsh, Metin Ozdemirli, Nazaneen N Grant, Deepa S Subramaniam

Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5

雌激素受体表达定量分析显示 SP1 抗体比 1D5 更敏感

Allison W Welsh, Malini Harigopal, Hallie Wimberly, Manju Prasad, David L Rimm

Cytoplasmic estrogen receptor in breast cancer

乳腺癌中的细胞质雌激素受体

Allison W Welsh, Donald R Lannin, Gregory S Young, Mark E Sherman, Jonine D Figueroa, N Lynn Henry, Lisa Ryden, Chungyeul Kim, Richard R Love, Rachel Schiff, David L Rimm

Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen

雌激素受体 mRNA 的定量原位测量可预测对他莫昔芬的反应

Jennifer M Bordeaux, Huan Cheng, Allison W Welsh, Bruce G Haffty, Donald R Lannin, Xingyong Wu, Nan Su, Xiao-Jun Ma, Yuling Luo, David L Rimm

Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells

乳腺癌雌激素受体测量的标准化表明假阴性结果取决于阈值强度,而不是阳性细胞的百分比

Allison W Welsh, Christopher B Moeder, Sudha Kumar, Peter Gershkovich, Elaine T Alarid, Malini Harigopal, Bruce G Haffty, David L Rimm

Analytic variability in immunohistochemistry biomarker studies

免疫组织化学生物标志物研究中的分析变异性

Valsamo K Anagnostou, Allison W Welsh, Jennifer M Giltnane, Summar Siddiqui, Camil Liceaga, Mark Gustavson, Konstantinos N Syrigos, Jill L Reiter, David L Rimm